US2009240044A1PendingUtilityA1
Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography
Est. expiryApr 23, 2024(expired)· nominal 20-yr term from priority
C07H 21/04C12N 15/101
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides methods for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography.
Claims
exact text as granted — not AI-modified1 . A method for reducing endotoxin levels in a nucleic acid solution, the method comprising:
a) contacting the nucleic acid solution with a carbohydrate non-ionic detergent selected from the group consisting of an alkyl thiomaltoside, a sucrose monoalkyl ester, and combinations thereof; b) contacting the solution resulting from step a) with an inorganic binding matrix; and c) washing the binding matrix resulting from step b) to obtain a nucleic acid composition having an endotoxin content of less than 100 EU/mg.
2 . The method of claim 1 , further comprising eluting the nucleic acid composition from the inorganic binding matrix of step c).
3 . The method of claim 2 , wherein the eluted nucleic acid composition comprises an average plasmid DNA yield of about 15 μg to about 50 μg and an average endotoxin level from about 20 EU/mg to about 100 EU/mg.
4 . The method of claim 1 , wherein the alkyl thiomaltoside is selected from the group consisting of n-decyl-β-D-thiomaltopyranoside, n-nonyl-β-D-thiomaltoside, and n-octyl-β-D-thiomaltopyranoside.
5 . The method of claim 1 , wherein the sucrose monoalkyl ester is selected from the group consisting of sucrose monodecanoate, n-monododecanoate-β-D-glucopyranoside, sucrose monolaurate, and n-octanoylsucrose.
6 . The method of claim 1 , wherein the inorganic binding matrix is selected from the group consisting of silica, diatomaceous earth, aluminum oxides, glass, titanium oxides, zirconium oxides, and hydroxyapatite.
7 . The method of claim 1 , wherein the inorganic binding matrix is silica.
8 . The method of claim 1 , wherein the nucleic acid solution is a plasmid DNA solution.
9 . The method of claim 1 , wherein the nucleic acid solution comprises double-stranded RNA or DNA, RNA/DNA hybrids, DNA fragments, oligonucleotides, amplified DNA or RNA, BACs, plasmid DNA, or a combination thereof.
10 . The method of claim 1 , wherein the nucleic acid solution from step a) comprises a binding solution.
11 . The method of claim 10 , wherein the binding solution comprises a chaotropic substance selected from the group consisting of a guanidinium salt, urea, an alkali thiocyanate, an alkali halide, an alkali perchlorate, and combinations thereof.
12 . The method of claim 11 , wherein the guanidinium salt is guanidine hydrochloride.
13 . The method of claim 1 , wherein step c) comprises washing with a binding solution, an alcohol solution, a carbohydrate non-ionic detergent, or a combination thereof.
14 . The method of claim 1 , further comprising obtaining the nucleic acid solution to be used in step a) from a biological source by a digestion method.
15 . The method of claim 14 , wherein the digestion method comprises alkaline lysis, centrifugation, filtration, or precipitation.
16 . The method of claim 1 , wherein the nucleic acid solution is a cleared lysate.
17 . A kit for reducing endotoxin levels in a nucleic acid solution, the kit comprising:
a) a binding solution; b) a carbohydrate non-ionic detergent; and c) an inorganic binding matrix.
18 . The kit of claim 17 , wherein the binding solution comprises a chaotropic substance selected from the group consisting of a guanidinium salt, urea, an alkali thiocyanate, an alkali halide, an alkali perchlorate, and combinations thereof.
19 . The kit of claim 18 , wherein the guanidinium salt is guanidine hydrochloride.
20 . The kit of claim 17 , wherein the carbohydrate non-ionic detergent is selected from the group consisting of an alkyl thioglucoside, an alkyl glucoside, an alkyl thiomaltoside, an alkyl maltosides, a sucrose monoalkyl esters, and combinations thereof.
21 . The kit of claim 17 , wherein the inorganic binding matrix is selected from the group consisting of silica, diatomaceous earth, aluminum oxides, glass, titanium oxides, zirconium oxides, and hydroxyapatite.
22 . The kit of claim 17 , wherein the inorganic binding matrix is silica.
23 . The kit of claim 18 , further comprising concentrated solutions for the preparation of wash solutions.
24 . The kit of claim 18 , further comprising an elution buffer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.